My watch list
my.bionity.com  
Login  

Development of a broad spectrum polymer‐released antimicrobial coating for the prevention of resistant strain bacterial infections

Abstract

More than 400,000 primary hip and knee replacement surgeries are performed each year in the United States. From these procedures, approximately 0.5–3% will become infected and when considering revision surgeries, this rate has been found to increase significantly. Antibiotic‐resistant bacterial infections are a growing problem in patient care. This in vitro research investigated the antimicrobial potential of the polymer released, broad spectrum, Cationic Steroidal Antimicrobial‐13 (CSA‐13) for challenges against 5 × 108 colony forming units (CFU) of methicillin‐resistant Staphylococcus aureus (MRSA). It was hypothesized that a weight‐to‐weight (w/w) concentration of 18% CSA‐13 in silicone would exhibit potent bactericidal potential when used as a controlled release device coating. When incorporated into a polymeric device coating, the 18% (w/w) broad‐spectrum polymer released CSA‐13 antimicrobial eliminated 5 × 108 CFU of MRSA within 8 h. In the future, these results will be utilized to develop a sheep model to assess CSA‐13 for the prevention of perioperative device‐related infections in vivo. © 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A:, 2012.

Authors:   K. D. Sinclair, T. X. Pham, R. W. Farnsworth, D. L. Williams, C. Loc‐Carrillo, L. A. Horne, S. H. Ingebretsen, R. D. Bloebaum
Journal:   Journal of Biomedical Materials Research Part A
Year:   2012
Pages:   n/a
DOI:   10.1002/jbm.a.34209
Publication date:   24-05-2012

Watchlist

This is where you can add this publication to your personal favourites.

Additional Information

Facts, background information, dossiers
More about Wiley
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE